Key Figures Q2 2003

Key Figures provide a succinct overview of the most significant developments for each period under review. You can view earlier quarters or years if you wish. Furthermore, you can find extensive reports by downloading press releases for the period of your choice.

Q2 operating profit at EUR 85 million and – in line with expectations – around Q1 2003 level, but 17% lower than in Q2 2002.

• Profit on ordinary activities after taxation EUR 67 million.
• During Q2 clear deterioration of market demand and considerably weaker US dollar.
• Volumes and margins under increased pressure in Q3 due to summer lull, leading to strongly lower Q3 operating profit compared with Q2.
• Clear recovery expected in Q4 compared with Q3 2003.
• Restructuring measures in preparation.
• Acquisition of Roche V&FC – at lower price and better conditions – expected to close in Q3; immediate contribution to profits thereafter.
• No indication of operating profit for 2003; it seems unlikely at present that 2002 level will be achieved.